uniQure N.V —— 季度现金流量表 (NASDAQ:QURE) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 556.54 M605.4 M584.89 M888.38 M824.91 M 负债总额 563.29 M571.72 M588.89 M659.64 M626.01 M 权益总额 -6.75 M33.69 M-4 M228.75 M198.9 M 负债及股东权益总额 556.54 M605.4 M584.89 M888.38 M824.91 M 总债务 51.32 M51.59 M51.84 M51.88 M49.7 M 净债务 -316.36 M-357.43 M-325.3 M-642.42 M-573.15 M

uniQure N.V

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

新闻

Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com

Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

A Unique Situation For UniQure (QURE)

瑞穗因FDA领导层变动上调uniQure股票评级

Mizuho upgrades uniQure stock rating on FDA leadership change

Avago, Lumentum among market cap stock movers on Monday

Chardan因FDA领导层变动上调uniQure股价目标

Chardan raises uniQure stock price target on FDA leadership change

Tesla and Facebook among market cap stock movers on Monday

Biotech Stocks Pop After CBER Chief Exit - Moderna (NASDAQ:MRNA)